Exosomes and Circulating Biomarkers Summit 2013

in Conferences May 22, 2013

SELECTBIO Inaugural Exosomes and Circulating Biomarkers 2013 Summit Focuses on Cutting-Edge Science and Presentations from Academic and Industrial Researchers.

This meeting brings together the basic biology of exosomes coupled with their emerging potential utility as carriers of cellular cargo representing a treasure trove of biomarkers for the development of diagnostics in the future.

This conference will include presentations as well as panel discussions facilitating exchange of unpublished information. In addition to the science, data on the business opportunities of exosomes will be presented. Networking opportunities abound with delegates from other conference tracks co-located with this event.

Finally, this conference brings together other classes of circulating biomarkers in an effort to provide an en bloc view of the current state of this field.

Keynote Speakers

Charles Cantor
Chief Scientific Officer, Sequenom

Bertrand Jordan
Emeritus Research Director, CNRS

Mostafa Ronaghi
Senior Vice President & Chief Technology Officer, Illumina Inc

Johan Skog
Chief Scientific Officer, Exosome Diagnostics

Call for Posters

You can also present your research on a poster while attending the meeting. Submit an abstract for consideration now!

Poster Submission Deadline: 31 August 2013

Agenda Topics

Classes of Circulating Biomarkers
- Epigenetic Biomarkers
- microRNA Biomarkers
- mRNA Biomarkers
- Protein Biomarkers
Emerging Themes in Research on Exosomes and Circulating Biomarkers
Exosome Biology
Exosomes as Sources of Circulating Biomarkers
Technologies for Capturing/Interrogating Circulating Biomarkers
Unmet Needs and Commercial Opportunities for Circulating Biomarkers

Sponsorship and Exhibition Opportunities

Jeff Fan, Exhibition Manager
Jeff@selectbio.us
+1 510-857-4865

(find out more…)

Speakers

Hsian-Rong Tseng, Professor, UCLA Geffen School of Medicine
Sunil Pandit, Senior Staff Biochemist, Siemens Healthcare Diagnostics
Dean Troyer, CEO, Provia Biologics
Christopher Cheng, Post Doctoral Researcher, Yale University
Leonora Balaj, Research Fellow, Mass General Hospital, Harvard Medical School
Iman Jilani, Associate Director, Pfizer
Dominique de Kleijn, Professor, National University of Singapore
Premal Shah, Director, Business Development, Genomic Health, Inc.
Robert Proulx, President, Silicon Biosystems
Karri Bradley, Partner, Klarquist Sparkmann, LLP
Gregory Scott, Patent Attorney, Klarquist Sparkman, LLP